Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000127905 | SCV000050836 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Gene |
RCV000127905 | SCV000171491 | benign | not specified | 2013-07-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000860223 | SCV001000203 | benign | Brugada syndrome 5 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000127905 | SCV005087584 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 55% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 51. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV004717058 | SCV005314861 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000127905 | SCV001921067 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000127905 | SCV001932152 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000127905 | SCV001954688 | benign | not specified | no assertion criteria provided | clinical testing |